Evidence map›Paper›PMID 38941056›Full record

ArticleJournal of pharmacokinetics and pharmacodynamics2024

pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization.

Xinnong Li, Mark Sale, Keith Nieforth, James Craig, Fenggong Wang, David Solit, Kairui Feng, Meng Hu, Robert Bies, Liang Zhao

Abstract readComparative Study
In one paragraph

Article in Journal of pharmacokinetics and pharmacodynamics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Rising Role of Artificial Intelligence in Clinical Pharmacometrics and Model-Informed Precision Dosing in Pediatrics.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  6. Article
  7. Article
  8. AI In Action: Redefining Drug Discovery and Development.Clinical and translational science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xinnong LiDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences State University of New York at Buffalo, Buffalo, NY, USA.ORCID 0009-0009-3002-4146
Mark SaleSoftware Product Development, Certara, Radnor, PA, USA.ORCID 0000-0002-6239-2359
Keith NieforthSoftware Product Development, Certara, Radnor, PA, USA.
James CraigSoftware Product Development, Certara, Radnor, PA, USA.ORCID 0000-0003-1757-9234
Fenggong WangDivision of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Montgomery, MD, USA.
David SolitMemorial Sloan Kettering, New York, NY, USA.
Kairui FengDivision of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Montgomery, MD, USA.
Meng HuDivision of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Montgomery, MD, USA.ORCID 0000-0003-2719-3263
Robert BiesDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences State University of New York at Buffalo, Buffalo, NY, USA. robertbi@buffalo.edu.ORCID 0000-0003-3818-2252
Liang ZhaoDivision of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Montgomery, MD, USA.ORCID 0000-0002-0257-9082

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Development of machine learning approaches to population pharmacokinetic model selection and evaluation of application to model-based bioequivalence analysis.U01FD007355 · FDA · NUVENTRA, INC. · PI SALE, MARK E · 2021 to 2022
$198k
FDA HHS U01 FD007355FDA/NIH 1U01FD007355NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Forward addition/backward elimination (FABE) has been the standard for population pharmacokinetic model selection (PPK) since NONMEM® was introduced. We investigated five machine learning (ML) algorithms (Genetic algorithm [GA], Gaussian process [GP], random forest [RF], gradient boosted random tree [GBRT], and particle swarm optimization [PSO]) as alternatives to FABE. These algorithms were applied to PPK model selection with a focus on comparing the efficiency and robustness of each of them. All machine learning algorithms included the combination of ML algorithms with a local downhill search. The local downhill search consisted of systematically changing one or two "features" at a time (a one-bit or a two-bit local search), alternating with the ML methods. An exhaustive search (all possible combinations of model features, N = 1,572,864 models) was the gold standard for robustness, and the number of models examined leading prior to identification of the final model was the metric for efficiency.All algorithms identified the optimal model when combined with the two-bit local downhill search. GA, RF, GBRT, and GP identified the optimal model with only a one-bit local search. PSO required the two-bit local downhill search. In our analysis, GP was the most efficient algorithm as measured by the number of models examined prior to finding the optimal (495 models), and PSO exhibited the least efficiency, requiring 1710 unique models before finding the best solution. Additionally, GP was also the algorithm that needed the longest elapsed time of 2975.6 min, in comparison with GA, which only required 321.8 min.

Indexed as

AlgorithmsMachine LearningNonlinear DynamicsComputer SimulationHumansModels, BiologicalPharmacokineticsBayesian optimizationGenetic algorithmMachine learningModelingPharmacokineticsRandom forest

Identifiers

PMID38941056
PMCPMC11579193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.